Disclosure of equipment sales broken down into laboratory and clinical diagnostics categories
First written in FY2025-H1. 4 of 5 entries say "Reframed", first in FY2025. Latest entry: FY2026.
Precision System Science moved to the "Worse" side of this theme in 2026.
2 other companies' latest entry also says "Reframed".
- FY2026ReframedAnnual report
「Previously, the categories were “equipment,” “reagents and consumables,” “maintenance-related,” and “contract manufacturing and contract testing,” but from the current consolidated fiscal year they have been changed to “equipment,” “reagents and consumables,” and “services and other.”」
The revenue categories were reorganized into 3 categories, with management reporting structured around a recurring business model based on equipment for genetic testing and dedicated reagents and consumables. - 2026-09-03ReframedGeneral Meetings of Shareholders
「The Company is currently focusing on developing a recurring business model based on genetic-testing instruments and the reagents and consumables used with them. The change reflects a corresponding review of the Company's management reporting segments.」
装置、試薬・消耗品、サービス・その他の3区分への変更理由として、リカーリングビジネスモデルを中心とする経営管理上の整理が明示された。 - FY2026-H1ReframedAnnual report
「Previously, revenue was categorized as “laboratory automation equipment,” “clinical diagnostic equipment,” “reagents and consumables,” “maintenance-related,” and “contract manufacturing and contract testing,” but from the current interim consolidated accounting period it has been changed to “equipment,” “reagents and consumables,” and “services and other.” We are currently focusing on developing a recurring business model based on equipment for genetic testing and the reagents and consumables used with that equipment. The change reflects a review of the management reporting categories accompanying this shift.」
The equipment categories introduced in the FY2025 interim period for laboratory and clinical diagnostic equipment were reorganized into 3 categories: equipment, reagents and consumables, and services and other. The change was described as placing a recurring business model based on genetic testing equipment and dedicated reagents and consumables at the center of management reporting. - FY2025ReframedAnnual report
「Previously, equipment was reported in 2 categories, “laboratory automation equipment” and “clinical diagnostic equipment,” but from the current consolidated accounting period it has been changed to a single category.」
The disclosure was changed from reporting equipment revenue separately for laboratory and clinical diagnostic equipment in the FY2025 interim period to presenting equipment as a single category for the full year. - FY2025-H1First statedAnnual report
「Previously, equipment was reported as a single category, but from the current interim consolidated accounting period it has been changed to 2 categories: “laboratory automation equipment” and “clinical diagnostic equipment.”」
Equipment revenue, previously presented in aggregate, was disclosed from the current interim consolidated accounting period in 2 categories: laboratory automation equipment and clinical diagnostic equipment.